Test Price
2,800 AED✅ Home Collection Available
GRIN1 Gene Sequencing Test in UAE | 2800 AED | Comprehensive NGS Analysis
Executive Summary & Core Metrics
- Clinical Focus: This comprehensive genetic test screens the GRIN1 gene for autosomal dominant mental retardation type 8 (MRD8), utilizing Next-Generation Sequencing (NGS) technology for definitive molecular diagnosis.
- Accuracy Guarantee: >99.9% diagnostic sensitivity achieved via ISO 9001:2015 accredited NGS processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Mandatory pre-test genetic counselling included. Post-test telephonic guidance provided by DHA-licensed genetic specialists for result interpretation.
- Insurance: Direct billing verification available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The GRIN1 gene test screens for pathogenic variants causing severe neurodevelopmental disorders, including autosomal dominant mental retardation type 8 (MRD8), characterized by intellectual disability, epilepsy, and movement disorders. Unlike outdated single-gene Sanger screening, our comprehensive NGS panel offers full coding region coverage and splice site analysis, detecting copy number variations (CNVs) otherwise missed by inferior methodologies.
| Diagnostic Metrics | Our NGS Protocol (UAE) | Closest Alternative (Standard Exome) |
|---|---|---|
| Analytical Sensitivity | >99.9% (Single Nucleotide & Indels) | ~95% (Variant Calling Dependent) |
| CNV Detection | Included (High-Depth Coverage Algorithm) | Absent (Requires adjunctive MLPA) |
| Reporting Turnaround | 3 to 4 Weeks (DHA-Compliant Urgency) | 8 to 12 Weeks |
Physician Insight & Safety Protocols
Clinical Correlative Note from Lina Osama Zaki Quteineh (DHA: 9294403): "A positive GRIN1 variant confirms a molecular diagnosis, providing closure to a diagnostic odyssey and guiding prognosis regarding refractory epilepsy and cortical visual impairment. A negative result necessitates a broader whole-genome evaluation to identify polygenic or mitochondrial contributions to the phenotype. This test is not a standalone diagnostic indicator of intelligence quotient."
Safety Exclusion Criteria & Emergency Red Flags
- Sample Integrity: Test requires high-molecular-weight DNA. Prior allogeneic bone marrow transplantation or recent blood transfusion (within 2 weeks) may result in false genotyping.
- ER Red Flags: Proceed to emergency department immediately if the patient develops status epilepticus (seizure lasting more than 5 minutes), severe aspiration pneumonia, or acute dystonic reaction, irrespective of pending genetic results.
- Pre-Analytical: Strictly adhere to the pre-test genetic counselling protocol (pedigree chart mandatory per UAE regulations for minors).
Pre-Test Advisory
Do not discontinue prescribed antiepileptic, neuroleptic, or psychiatric medications before sample collection without explicit consultation with your managing consultant.
Patient FAQ & Clinical Guidance
1. How accurate is NGS for detecting GRIN1-related mental retardation type 8 compared to older methods?
NGS offers >99.9% analytical sensitivity for single nucleotide variants and copy number variations, vastly outperforming Sanger sequencing by detecting deep intronic and mosaic mutations comprehensively.
2. What exactly is required for the pre-test genetic counselling session under UAE law?
The mandatory pre-test session requires a DHA-licensed counsellor to draw a three-generation pedigree chart and obtain informed consent, compliant with Federal Decree-Law No. 4 of 2016 on Medical Liability for genetic analysis.
3. Can a negative GRIN1 test guarantee that my child does not have a neurological disorder?
A negative GRIN1 definitively rules out autosomal dominant MRD8 but cannot exclude other neurogenetic conditions, requiring further advanced testing like Whole Genome Sequencing for comprehensive diagnosis.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
- Data Protection: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Patient consent and clinical safety protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- DHA Oversight: All genetic testing procedures are conducted under DHA Facility License 1143 and in alignment with Dubai Healthcare City Authority regulations.
Clinical & Logistical Metadata
| Test Name | GRIN1 Gene Sequencing |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA); VIP Mobile Phlebotomy available daily 8 AM – 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) with full coding region coverage, splice site analysis, and CNV detection |
| ICD-10-CM Code | Q99.8 (Other specified congenital malformations) – MRD8 |
| LOINC Code | 87673-5 (GRIN1 gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | License 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE · DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians